Total Payments
$9,316
2024 Payments
$1,524
Companies
47
Transactions
540
Medicare Patients
3,500
Medicare Billing
$152,315
Payment Breakdown by Category
Food & Beverage$9,244 (99.2%)
Education$55.97 (0.6%)
Other$15.54 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,244 | 529 | 99.2% |
| Education | $55.97 | 10 | 0.6% |
| Entertainment | $15.54 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,788 | 88 | $0 (2024) |
| Lilly USA, LLC | $1,090 | 61 | $0 (2024) |
| Novo Nordisk Inc | $779.71 | 47 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $773.98 | 35 | $0 (2024) |
| GlaxoSmithKline, LLC. | $750.23 | 52 | $0 (2024) |
| PFIZER INC. | $691.37 | 53 | $0 (2024) |
| Amgen Inc. | $576.42 | 29 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $242.00 | 14 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $214.59 | 14 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $201.94 | 20 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,524 | 83 | ABBVIE INC. ($260.05) |
| 2023 | $2,387 | 117 | ABBVIE INC. ($572.10) |
| 2022 | $2,127 | 119 | ABBVIE INC. ($558.29) |
| 2021 | $1,532 | 100 | AbbVie Inc. ($397.15) |
| 2020 | $314.45 | 22 | AstraZeneca Pharmaceuticals LP ($57.41) |
| 2019 | $308.75 | 23 | GlaxoSmithKline, LLC. ($52.26) |
| 2018 | $665.57 | 49 | Takeda Pharmaceuticals U.S.A., Inc. ($112.31) |
| 2017 | $456.98 | 27 | Allergan Inc. ($55.75) |
All Payment Transactions
540 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: VACCINES | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $3.09 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Gastroenterology | ||||||
| 10/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Gastroenterology | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Obesity | ||||||
| 10/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: PAIN | ||||||
| 10/03/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Bone Health | ||||||
| 09/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Inflammation | ||||||
| 09/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: PAIN | ||||||
| 08/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $2.61 | General |
| Category: PAIN | ||||||
| 08/29/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Oncology | ||||||
| 08/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: PAIN | ||||||
| 08/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $27.23 | General |
| Category: Bone Health | ||||||
| 08/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Inflammation | ||||||
| 08/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.34 | General |
| Category: PAIN | ||||||
| 08/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Diabetes Care | ||||||
| 07/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,081 | 1,513 | $121,650 | $48,393 |
| 2022 | 31 | 1,003 | 1,355 | $113,267 | $46,517 |
| 2021 | 26 | 881 | 1,102 | $90,485 | $35,151 |
| 2020 | 17 | 535 | 630 | $58,224 | $22,253 |
Total Patients
3,500
Total Services
4,600
Medicare Billing
$152,315
Procedure Codes
102
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 114 | 230 | $37,260 | $19,224 | 51.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 55 | 55 | $14,080 | $6,885 | 48.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 108 | $11,880 | $5,833 | 49.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $5,819 | $3,097 | 53.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 110 | 223 | $3,568 | $1,873 | 52.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 18 | 19 | $1,311 | $1,285 | 98.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 80 | 90 | $7,380 | $1,181 | 16.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 85 | 107 | $6,634 | $1,107 | 16.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 95 | 125 | $4,500 | $951.25 | 21.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 46 | 53 | $3,975 | $872.38 | 21.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 26 | 27 | $2,457 | $783.27 | 31.9% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 16 | 19 | $2,413 | $768.55 | 31.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 47 | 78 | $4,836 | $742.56 | 15.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 22 | $682.00 | $658.68 | 96.6% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 25 | 28 | $2,856 | $413.84 | 14.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $372.00 | $359.28 | 96.6% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 17 | 25 | $1,050 | $334.00 | 31.8% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 27 | 34 | $1,394 | $281.86 | 20.2% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 41 | 49 | $3,136 | $277.34 | 8.8% |
| 80069 | Kidney function blood test panel | Office | 2023 | 23 | 31 | $837.00 | $263.81 | 31.5% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 41 | 49 | $1,372 | $248.92 | 18.1% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 12 | 12 | $684.00 | $227.04 | 33.2% |
| 82746 | Folic acid level, serum | Office | 2023 | 11 | 12 | $540.00 | $172.92 | 32.0% |
| 83550 | Iron binding capacity | Office | 2023 | 16 | 19 | $950.00 | $162.83 | 17.1% |
| 80076 | Liver function blood test panel | Office | 2023 | 16 | 18 | $450.00 | $144.18 | 32.0% |
About Dr. Christopher Normile, MD
Dr. Christopher Normile, MD is a Family Medicine healthcare provider based in Saint Charles, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578530945.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Normile, MD has received a total of $9,316 in payments from pharmaceutical and medical device companies, with $1,524 received in 2024. These payments were reported across 540 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($9,244).
As a Medicare-enrolled provider, Normile has provided services to 3,500 Medicare beneficiaries, totaling 4,600 services with total Medicare billing of $152,315. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Saint Charles, MO
- Active Since 03/03/2006
- Last Updated 02/28/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1578530945
Products in Payments
- VRAYLAR (Drug) $750.67
- UBRELVY (Drug) $590.19
- TRULICITY (Drug) $463.30
- QULIPTA (Drug) $446.73
- FARXIGA (Drug) $392.60
- EMGALITY (Drug) $358.58
- TRELEGY ELLIPTA (Drug) $317.33
- Ozempic (Drug) $294.21
- BREZTRI (Drug) $292.88
- NURTEC ODT (Drug) $290.03
- MOUNJARO (Drug) $206.44
- REXULTI (Drug) $201.34
- XARELTO (Drug) $187.51
- ELIQUIS (Drug) $175.99
- EVENITY (Biological) $172.27
- Rybelsus (Drug) $167.29
- JARDIANCE (Drug) $166.14
- Otezla (Drug) $163.16
- SHINGRIX (Biological) $149.51
- Trintellix (Drug) $138.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Saint Charles
Dr. Hemalini Thakkar, M.d, M.D
Family Medicine — Payments: $12,488
Family Medicine $12,488
Elizabeth Maylack, D.o, D.O
Family Medicine — Payments: $7,183
Family Medicine $7,183
Dr. Steven Livingstone, D.o, D.O
Family Medicine — Payments: $4,129
Family Medicine $4,129
Michael Houser, M.d, M.D
Family Medicine — Payments: $3,063
Family Medicine $3,063
Stacy Jefferson, M.d, M.D
Family Medicine — Payments: $2,483
Family Medicine $2,483
Ann Lottes, M.d, M.D
Family Medicine — Payments: $1,828
Family Medicine $1,828